as.novak
Submits third-party assay reports on material purchased directly. Based in Izmir.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.14%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041461 | Retatrutide | QYB | QYB-2604-B5660 | Janoshik | 2026-Q3 | 99.14 | 2.29 | 97.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041908 | TB-500 | JEEP | JEEP-2510-R4058 | Janoshik | 2026-Q1 | 99.93 | 5.24 | 97.4 | Supplier-supplied | 0 | PASS |
| AX-2025-018557 | IGF-1 LR3 | WWB | WWB-2504-J3824 | PeptideMeter | 2025-Q3 | 98.80 | 7.05 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019805 | Semaglutide | HJ | HJ-2507-P3933 | Janoshik | 2025-Q3 | 98.87 | 4.41 | 89.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019764 | Semaglutide | HJ | HJ-2504-Y4203 | PeptideMeter | 2025-Q2 | 99.45 | 4.68 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020276 | Enclomiphene citrate | MKM | MKM-2408-L2880 | Nordanalyt | 2025-Q1 | 97.85 | 4.03 | 89.6 | Buyer-sourced | 2 | FAIL |
| AX-2025-020459 | Liraglutide | KP | KP-2502-E5076 | Janoshik | 2025-Q1 | 99.14 | 6.66 | 104.4 | Supplier-supplied | 0 | PASS |